Table of Content

1 Betahistine Market Overview
1.1 Product Overview and Scope of Betahistine
1.2 Betahistine Segment by Type
1.2.1 Global Betahistine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 8mg
1.2.3 25mg
1.2.4 Others
1.3 Betahistine Segment by Application
1.3.1 Betahistine Sales Comparison by Application: (2021-2027)
1.3.2 Cerebral Thrombosis
1.3.3 Cerebral Embolism
1.3.4 Others
1.4 Global Betahistine Market Size Estimates and Forecasts
1.4.1 Global Betahistine Revenue 2016-2027
1.4.2 Global Betahistine Sales 2016-2027
1.4.3 Betahistine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Betahistine Market Competition by Manufacturers
2.1 Global Betahistine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Betahistine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Betahistine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Betahistine Manufacturing Sites, Area Served, Product Type
2.5 Betahistine Market Competitive Situation and Trends
2.5.1 Betahistine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Betahistine Players Market Share by Revenue
2.5.3 Global Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Betahistine Retrospective Market Scenario by Region
3.1 Global Betahistine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Betahistine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Betahistine Market Facts & Figures by Country
3.3.1 North America Betahistine Sales by Country
3.3.2 North America Betahistine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Betahistine Market Facts & Figures by Country
3.4.1 Europe Betahistine Sales by Country
3.4.2 Europe Betahistine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Betahistine Market Facts & Figures by Region
3.5.1 Asia Pacific Betahistine Sales by Region
3.5.2 Asia Pacific Betahistine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Betahistine Market Facts & Figures by Country
3.6.1 Latin America Betahistine Sales by Country
3.6.2 Latin America Betahistine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Betahistine Market Facts & Figures by Country
3.7.1 Middle East and Africa Betahistine Sales by Country
3.7.2 Middle East and Africa Betahistine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Betahistine Historic Market Analysis by Type
4.1 Global Betahistine Sales Market Share by Type (2016-2021)
4.2 Global Betahistine Revenue Market Share by Type (2016-2021)
4.3 Global Betahistine Price by Type (2016-2021)

5 Global Betahistine Historic Market Analysis by Application
5.1 Global Betahistine Sales Market Share by Application (2016-2021)
5.2 Global Betahistine Revenue Market Share by Application (2016-2021)
5.3 Global Betahistine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 TOWA PHARMACEUTICAL CO., LTD
6.1.1 TOWA PHARMACEUTICAL CO., LTD Corporation Information
6.1.2 TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
6.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 TOWA PHARMACEUTICAL CO., LTD Product Portfolio
6.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments/Updates
6.2 Nichi-Iko Pharmaceutical
6.2.1 Nichi-Iko Pharmaceutical Corporation Information
6.2.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Nichi-Iko Pharmaceutical Product Portfolio
6.2.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceutical Company Limited
6.3.1 Takeda Pharmaceutical Company Limited Corporation Information
6.3.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Takeda Pharmaceutical Company Limited Product Portfolio
6.3.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.4 EA Pharma Co., Ltd.
6.4.1 EA Pharma Co., Ltd. Corporation Information
6.4.2 EA Pharma Co., Ltd. Description and Business Overview
6.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 EA Pharma Co., Ltd. Product Portfolio
6.4.5 EA Pharma Co., Ltd. Recent Developments/Updates
6.5 Disphar International B.V.
6.5.1 Disphar International B.V. Corporation Information
6.5.2 Disphar International B.V. Description and Business Overview
6.5.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Disphar International B.V. Product Portfolio
6.5.5 Disphar International B.V. Recent Developments/Updates
6.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
6.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
6.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Business Overview
6.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Product Portfolio
6.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments/Updates
6.7 DOC Generici
6.6.1 DOC Generici Corporation Information
6.6.2 DOC Generici Description and Business Overview
6.6.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 DOC Generici Product Portfolio
6.7.5 DOC Generici Recent Developments/Updates
6.8 Ciclum Farma Unipessoal
6.8.1 Ciclum Farma Unipessoal Corporation Information
6.8.2 Ciclum Farma Unipessoal Description and Business Overview
6.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ciclum Farma Unipessoal Product Portfolio
6.8.5 Ciclum Farma Unipessoal Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Mylan Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Orion Corporation
6.10.1 Orion Corporation Corporation Information
6.10.2 Orion Corporation Description and Business Overview
6.10.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Orion Corporation Product Portfolio
6.10.5 Orion Corporation Recent Developments/Updates

7 Betahistine Manufacturing Cost Analysis
7.1 Betahistine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Betahistine
7.4 Betahistine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Betahistine Distributors List
8.3 Betahistine Customers

9 Betahistine Market Dynamics
9.1 Betahistine Industry Trends
9.2 Betahistine Growth Drivers
9.3 Betahistine Market Challenges
9.4 Betahistine Market Restraints

10 Global Market Forecast
10.1 Betahistine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Betahistine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Betahistine by Type (2022-2027)
10.2 Betahistine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Betahistine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Betahistine by Application (2022-2027)
10.3 Betahistine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Betahistine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Betahistine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Betahistine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Betahistine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Betahistine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Betahistine Covered in This Study
Table 5. Global Betahistine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Betahistine Sales Share by Manufacturers (2016-2021)
Table 7. Global Betahistine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Betahistine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Betahistine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Betahistine Manufacturing Sites and Area Served
Table 11. Manufacturers Betahistine Product Type
Table 12. Global Betahistine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Betahistine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Betahistine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Betahistine Sales by Region (2016-2021) & (K Units)
Table 16. Global Betahistine Sales Market Share by Region (2016-2021)
Table 17. Global Betahistine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Betahistine Sales by Country (2016-2021) & (K Units)
Table 19. North America Betahistine Sales Market Share by Country (2016-2021)
Table 20. North America Betahistine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Betahistine Revenue Market Share by Country (2016-2021)
Table 22. Europe Betahistine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Betahistine Sales Market Share by Country (2016-2021)
Table 24. Europe Betahistine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Betahistine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Betahistine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Betahistine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Betahistine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Betahistine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Betahistine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Betahistine Sales Market Share by Country (2016-2021)
Table 32. Latin America Betahistine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Betahistine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Betahistine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Betahistine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Betahistine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Betahistine Revenue Market Share by Country (2016-2021)
Table 38. Global Betahistine Sales (K Units) by Type (2016-2021)
Table 39. Global Betahistine Sales Market Share by Type (2016-2021)
Table 40. Global Betahistine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Betahistine Revenue Share by Type (2016-2021)
Table 42. Global Betahistine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Betahistine Sales (K Units) by Application (2016-2021)
Table 44. Global Betahistine Sales Market Share by Application (2016-2021)
Table 45. Global Betahistine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Betahistine Revenue Share by Application (2016-2021)
Table 47. Global Betahistine Price (US$/Unit) by Application (2016-2021)
Table 48. TOWA PHARMACEUTICAL CO., LTD Corporation Information
Table 49. TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
Table 50. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. TOWA PHARMACEUTICAL CO., LTD Betahistine Product
Table 52. TOWA PHARMACEUTICAL CO., LTD Recent Developments/Updates
Table 53. Nichi-Iko Pharmaceutical Corporation Information
Table 54. Nichi-Iko Pharmaceutical Description and Business Overview
Table 55. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Nichi-Iko Pharmaceutical Betahistine Product
Table 57. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 58. Takeda Pharmaceutical Company Limited Corporation Information
Table 59. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 60. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Takeda Pharmaceutical Company Limited Betahistine Product
Table 62. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 63. EA Pharma Co., Ltd. Corporation Information
Table 64. EA Pharma Co., Ltd. Description and Business Overview
Table 65. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. EA Pharma Co., Ltd. Betahistine Product
Table 67. EA Pharma Co., Ltd. Recent Developments/Updates
Table 68. Disphar International B.V. Corporation Information
Table 69. Disphar International B.V. Description and Business Overview
Table 70. Disphar International B.V. Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Disphar International B.V. Betahistine Product
Table 72. Disphar International B.V. Recent Developments/Updates
Table 73. HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
Table 74. HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Business Overview
Table 75. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product
Table 77. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments/Updates
Table 78. DOC Generici Corporation Information
Table 79. DOC Generici Description and Business Overview
Table 80. DOC Generici Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. DOC Generici Betahistine Product
Table 82. DOC Generici Recent Developments/Updates
Table 83. Ciclum Farma Unipessoal Corporation Information
Table 84. Ciclum Farma Unipessoal Description and Business Overview
Table 85. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Ciclum Farma Unipessoal Betahistine Product
Table 87. Ciclum Farma Unipessoal Recent Developments/Updates
Table 88. Mylan Corporation Information
Table 89. Mylan Description and Business Overview
Table 90. Mylan Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Mylan Betahistine Product
Table 92. Mylan Recent Developments/Updates
Table 93. Orion Corporation Corporation Information
Table 94. Orion Corporation Description and Business Overview
Table 95. Orion Corporation Betahistine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Orion Corporation Betahistine Product
Table 97. Orion Corporation Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Betahistine Distributors List
Table 101. Betahistine Customers List
Table 102. Betahistine Market Trends
Table 103. Betahistine Growth Drivers
Table 104. Betahistine Market Restraints
Table 105. Global Betahistine Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Betahistine Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Betahistine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Betahistine Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Betahistine Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Betahistine Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Betahistine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Betahistine Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Betahistine Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Betahistine Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Betahistine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Betahistine Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Betahistine
Figure 2. Global Betahistine Market Share by Type in 2020 & 2027
Figure 3. 8mg Product Picture
Figure 4. 25mg Product Picture
Figure 5. Others Product Picture
Figure 6. Global Betahistine Market Share by Application in 2020 & 2027
Figure 7. Cerebral Thrombosis
Figure 8. Cerebral Embolism
Figure 9. Others
Figure 10. Global Betahistine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Betahistine Market Size 2016-2027 (US$ Million)
Figure 12. Global Betahistine Sales 2016-2027 (K Units)
Figure 13. Global Betahistine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Betahistine Sales Share by Manufacturers in 2020
Figure 15. Global Betahistine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Betahistine Players: Market Share by Revenue in 2020
Figure 17. Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Betahistine Sales Market Share by Region (2016-2021)
Figure 19. Global Betahistine Sales Market Share by Region in 2020
Figure 20. Global Betahistine Revenue Market Share by Region (2016-2021)
Figure 21. Global Betahistine Revenue Market Share by Region in 2020
Figure 22. U.S. Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Betahistine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Betahistine by Type (2016-2021)
Figure 47. Sales Market Share of Betahistine by Application (2016-2021)
Figure 48. Sales Market Share of Betahistine by Application in 2020
Figure 49. Revenue Share of Betahistine by Application (2016-2021)
Figure 50. Revenue Share of Betahistine by Application in 2020
Figure 51. Manufacturing Cost Structure of Betahistine
Figure 52. Manufacturing Process Analysis of Betahistine
Figure 53. Betahistine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed